RAPT: RAPT Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 38.45
Enterprise Value ($M) 0.55
Book Value ($M) 95.51
Book Value / Share 2.73
Price / Book 0.40
NCAV ($M) 89.64
NCAV / Share 2.56
Price / NCAV 0.43

Profitability (mra)
Return on Invested Capital (ROIC) -1.07
Return on Assets (ROA) -0.54
Return on Equity (ROE) -0.62

Liquidity (mrq)
Quick Ratio 9.90
Current Ratio 9.90

Balance Sheet (mrq) ($M)
Current Assets 102.60
Assets 108.47
Liabilities 12.96
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
6 days ago 13G/A Deep Track Capital, LP 0.00 -100.00
6 days ago 13G/A Price T Rowe Associates Inc /md/ 0.50 -94.85
8 days ago 13G/A Vanguard Group Inc 9.04 0.00
8 days ago 13G/A Fmr Llc 15.00 36.22
02-14 13G/A Redmile Group, LLC 9.90 2.64
02-14 13G/A Perceptive Advisors Llc 6.20 18.96
01-26 13G/A BlackRock, Inc. 7.10 28.87
01-23 13G/A State Street Corp 4.23 -25.05

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-07 10-K Form 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-19 100,487 444,368 22.61
2024-11-18 269,658 1,168,771 23.07
2024-11-15 250,994 952,869 26.34
2024-11-14 462,577 1,245,605 37.14

(click for more detail)

Similar Companies
PWUP – PowerUp Acquisition Corp. QTTB – Q32 Bio Inc.
RANI – Rani Therapeutics Holdings, Inc. RCKT – Rocket Pharmaceuticals, Inc.
RLAY – Relay Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io